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NO-donating oximes relax corpora cavernosa through 
mechanisms other than those involved in arterial relaxation. 
INTRODUCTION: Erectile dysfunction (ED) as well as many cardiovascular diseases are 
associated with impaired NO-bioavailability. Recently, oxime derivatives have emerged as 
vasodilators due to their NO-donating capacities. However, whether these oximes offer 
therapeutic perspectives as alternative NO-delivery strategy for the treatment of ED is 
unexplored.  
AIMS: This study aims to analyze the influence of formaldoxime (FAL), formamidoxime 
(FAM) and cinnamaldoxime (CAOx) on corporal tension and to elucidate the underlying 
molecular mechanisms. 
METHODS: Organ bath studies were carried out measuring isometric tension on isolated 
mice corpora cavernosa (CC), thoracic aorta and femoral artery. After contraction with 
norepinephrine (NOR), cumulative concentration-response curves of FAL, FAM and CAOx 
(100 nmol/L–1 mmol/L) were performed.  
MAIN OUTCOME MEASURES: FAL-/FAM-induced relaxations were evaluated in the 
absence/presence of various inhibitors of different molecular pathways.  
RESULTS: FAL, FAM and CAOx relax isolated CC as well as aorta and femoral artery from 
mice. ODQ (sGC-inhibitor), DPI (non-selective flavoprotein inhibitor) and 7-ER (inhibitor of 
CYP450 1A1 and NADPH-dependent reductases) substantially blocked the FAL-/FAM-
induced relaxation in the arteries, but not in CC. Only a small inhibition of the FAM response 
was observed with ODQ.  
CONCLUSIONS: This study shows for the first time that NO-donating oximes relax mice 
CC. Therefore oximes are a new group of molecules with potential for the treatment of ED. 
However, the underlying mechanism(s) of the FAL-/FAM-induced corporal relaxation clearly 
differ(s) from the one(s) involved in arterial vasorelaxation.  
